Recipharm pairs up with Adroit for chemistry services

Contract drug developer Recipharm has inked a deal with Adroit Science to join forces in drug formulation. Adroit, a specialist in characterization, will contribute its services to Recipharm's existing platform of API development and chemical analysis, creating a combined platform the partners say will stand out on the market. More

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.